Table 1 from The MATTERS Trial: Safety and Tolerability of Whole-Body Hyperthermia at 41.50°C in Combination with Chemotherapy in Metastatic Cancer Patients
收藏NIAID Data Ecosystem2026-05-10 收录
数据链接：
官方服务：
资源简介：
Patient demographics, clinical status, prior treatments (not chronologically sorted), cohort assignment, and screening outcomes for participants enrolled or screened in the MATTERS study.
创建时间：
2026-02-04
